In Vitro Efficacy Evaluation for Cancer Therapy
Solutions
Online Inquiry

In Vitro Efficacy Evaluation for Cancer Therapy

With the rising incidence of cancer, the demand for therapy grows urgent. In the multi-stage process of cancer drug development, in vitro efficacy assessment stands as a crucial step. Alfa Cytology pledges to deliver top-notch experimental outcomes and comprehensive reports, ensuring reliability and accuracy through rigorous quality control measures, thereby furnishing dependable data support for your cancer therapy evaluations.

Overview of In Vitro Efficacy Evaluation

In vitro assessment of drug efficacy is pivotal in drug discovery and development, swiftly and efficiently evaluating the effectiveness and safety of cancer drugs. It serves as a crucial reference for subsequent trials. By utilizing diverse cellular models and experimental techniques, in vitro evaluation aids researchers in predicting cancer drug effects in vivo, refining drug design, screening potential therapeutic candidates, and enhancing R&D efficiency.

In Vitro Efficacy Evaluation Models

Comparison of 2D, 3D, and microfluidic chip in vitro cell culture modelsFig.1 Comparison of in vitro cell culture models. (Lee, S. J., & Lee, H. A., 2020)

The in vitro assessment of anticancer drug efficacy has become an indispensable method, eliminating the need for biomarker validation, and offering deeper insights into the complex effectiveness of these drugs. Researchers have employed various preclinical in vitro models, such as traditional cell cultures and tumor microarray models, to produce reliable and reproducible predictions of anticancer drug outcomes.

Our Services

Recognizing the significance of in vitro assessment for cancer drugs, Alfa Cytology offers specialized in vitro efficacy evaluation services. Utilizing advanced cell modeling and experimental methods, we swiftly and precisely evaluate the anticancer potency and safety of drug candidates, offering crucial support for drug development.

Alfa Cytology offers a range of assays designed to evaluate the impact of cancer drugs on tumor cells in vitro. These assays are categorized based on their specific objectives and the methodologies employed.

Cell Proliferation and Cytotoxicity Assays

  • MTT/MTS Assay
  • XTT/CCK-8 Assay
  • LDH Assay

Molecular Mechanism Studies

  • Western Blotting
  • qPCR
  • RNA-Seq

Cell Migration and Invasion Assays

  • Wound Healing Assay
  • Transwell Migration

Apoptosis and Cell Death Assays

  • Annexin V/Pl Staining
  • TUNEL Assay
  • Caspase Activity Assays

3D Cell Culture and Organoid Testing

  • Spheroid Formation Assay
  • Organoid Culture

Drug Combination Screening

  • Synergy Assays
  • Dose-Response Matrix

Cell Cycle Analysis

  • Pl Staining and Flow Cytometry
  • BrdU incorporation Assay

Co-culture System Evaluation

  • Tumor-Stroma Co-culture
  • lmmune Cell Co-culture

Drug Resistance Evaluation

  • Long-term Drug Treatment
  • Resistance Marker Analysis

Workflow of Our Imaging Services

Contact Our Scientists

Reach out to our team to discuss your project requirements and explore how our solutions can meet your needs.

Confirming Study Protocols

As experts in cancer research, our team is ready to collaborate with you to advance your research.

Preparing Cellular Models

Tailored preclinical in vitro drug evaluation models are customized to meet specific research requirements.

Assessing Drug Efficacy

Customize preclinical in vitro drug evaluation models to meet specific study requirements.

Analyzing Data & Providing Reports

We assess drug efficacy against cancer cells, analyze data meticulously, and provide comprehensive reports.

Improve your cancer drug research with Alfa Cytology's in vitro efficacy evaluation services. Whether you're evaluating drug efficacy, investigating tumor response, or refining treatment strategies, our thorough evaluations can enhance your research outcomes. Feel free to contact us for more details on our services.

Reference

  1. Lee, S. J., & Lee, H. A. (2020). Trends in the development of human stem cell-based non-animal drug testing models. The Korean Journal of Physiology & Pharmacology: Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology, 24(6), 441.

For research use only.